IP Library Assignment 028590/0308
Patent Assignment
Reel/Frame 028590/0308

Assignment of Assignor's Interest

Recorded: 2012-07-19 Pages: 5
Assignor
BERG BIOSYSTEMS, LLC
Executed: 2012-06-11
Assignee
BERG PHARMA LLC
1845 ELM HILL PIKE, NASHVILLE, TENNESSEE, 37210
Covered Properties (19)
Methods for Treatment of Oncological Disorders Using an Epimetabolic Shifter (Coenzyme Q10)
Application: 61/177,241 →
Methods for Treatment of Oncological Disorders Using an Epimetabolic Shifter (Coenzyme Q10)
Application: 12/778,094 →
Publication: US US20110027247A1
Methods for Treatment of Oncological Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Application: 61/177,243 →
Methods for Treatment of Oncological Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Application: 12/777,902 →
Publication: US US20110110914A1
Methods for the Diagnosis of Oncological Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Application: 61/177,244 →
Methods for the Diagnosis of Oncological Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Patent: 9,205,064 →
Application: 12/778,029 →
Publication: US US20110123987A1
Methods for Treatment of Metabolic Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Application: 61/177,245 →
Methods for Treatment of Metabolic Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Application: 12/778,054 →
Publication: US US20110020312A1
Methods for the Diagnosis of Metabolic Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Application: 61/177,246 →
Methods for the Diagnosis of Metabolic Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers
Application: 12/778,010 →
Publication: US US20110123986A1
Vitamin D3 and Analogs Thereof for Alleviating Side Effects Associated with Chemotherapy
Application: 61/147,549 →
Vitamin D3 and Analogs Thereof for Alleviating Side Effects Associated with Chemotherapy
Application: 61/239,003 →
Vitamin D3 and Analogs Thereof for Alleviating Side Effects Associated with Chemotherapy
Application: 12/695,113 →
Publication: US US20100196308A1
Vitamin D3 and Analogs Thereof for Treating Alopecia
Application: 61/234,178 →
Vitamin D3 and Analogs Thereof for Treating Alopecia
Patent: 9,901,637 →
Application: 12/853,431 →
Publication: US US20110059917A1
Assay System for the Assessment of Oncogenicity, Tumor Progression, and Treatment Efficacy
Application: 61/023,570 →
Assay System for the Assessment of Oncogenicity, Tumor Progression, and Treatment Efficacy
Application: 12/864,185 →
Publication: US US20110027811A1
Interrogatory Cell-Based Assays And Uses Thereof
Application: 61/448,587 →
Interrogatory Cell-Based Assays and Uses Thereof
Application: 61/593,848 →
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 6, 2012
From: NARAIN, NIVEN RAJIN; SARANGARAJAN, RANGAPRASAD; VISHNUDAS, VIVEK KANNOTH
To: BERG BIOSYSTEMS, LLC
Reel/Frame 027817/0890 →
Change of Name Jul 22, 2015
From: BERG PHARMA LLC
To: BERG LLC
Reel/Frame 036160/0430 →
Change of Name Jan 11, 2016
From: BERG PHARMA LLC
To: BERG LLC
Reel/Frame 037484/0248 →
Change of Name May 4, 2016
From: BERG PHARMA LLC
To: BERG LLC
Reel/Frame 038603/0110 →
Change of Name May 11, 2016
From: BERG PHARMA LLC
To: BERG LLC
Reel/Frame 038674/0912 →
Change of Name May 12, 2016
From: BERG PHARMA LLC
To: BERG LLC
Reel/Frame 038691/0434 →
Assignment of Assignor's Interest Jun 2, 2023
From: BERG LLC
To: BPGBIO, INC.
Reel/Frame 063842/0405 →
Security Interest Apr 21, 2025
From: BPGBIO INC.
To: PHOENIX GENESIS LLC
Reel/Frame 070903/0693 →
Corrective Assignment to Correct the Patent Number 8147825 Was Added Previously Recorded at Reel: 70903 Frame: 693. Assignor(S) Hereby Confirms the Security Agreement. Apr 30, 2025
From: BPGBIO INC.
To: PHOENIX GENESIS LLC
Reel/Frame 071285/0001 →
Security Interest Aug 29, 2025
From: BPGBIO INC.
To: BERG SURVIVOR’S TRUST; BERG, KARA ANN; THLIVERIS, ANDREW T.
Reel/Frame 072805/0303 →